Publications:

Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer.

Bmc Cancer

Masuda, Norikazu N; Tamura, Kenji K; Yasojima, Hiroyuki H; Shimomura, Akihiko A; Sawaki, Masataka M; Lee, Min-Jung MJ; Yuno, Akira A; Trepel, Jane J; Kimura, Ryoko R; Nishimura, Yozo Y; Saji, Shigehira S; Iwata, Hiroji H

Publication Date: 2021-11-24

Variant appearance in text: HR: D34A

PubMed Link: 34819039

Variant Present in the following documents:

• Main text

View BVdb publication page

UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity.

Nature

Majer, Olivia O; Liu, Bo B; Kreuk, Lieselotte S M LSM; Krogan, Nevan N; Barton, Gregory M GM

Publication Date: 2019-11

Variant appearance in text: HR: D34A

PubMed Link: 31546246

Variant Present in the following documents:

• Main text
• nihms-1538234.pdf

View BVdb publication page

E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.

Basic Research In Cardiology

Dassanayaka, Sujith S; Brittian, Kenneth R KR; Jurkovic, Andrea A; Higgins, Lauren A LA; Audam, Timothy N TN; Long, Bethany W BW; Harrison, Linda T LT; Militello, Giuseppe G; Riggs, Daniel W DW; Chitre, Mitali G MG; Uchida, Shizuka S; Muthusamy, Senthilkumar S; Gumpert, Anna M AM; Jones, Steven P SP

Publication Date: 2019-05-31

Variant appearance in text: HR: D34A

PubMed Link: 31152247

Variant Present in the following documents:

• Main text

View BVdb publication page